1Bedogni G,Miglioli L,Masutti F,et al.Prevalence of and risk factors for nonalcoholic fatty liver disease:the Dionysos nutrition and liver study[].Hepatology.2005
2Fan JG,Zhu J,Li XJ,et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai,China[].Journal of Hepatology.2005
3Jansen PL.Non-alcoholic steatohepatitis[].European Journal of Gastroenterology and Hepatology.2004
4Eng FJ,Friedman SL,Fibrogenesis I.New insights into hep-atic stellate cell activation:the simple becomes complex[].American Journal of Physiology Gastrointestinal and Liver Physiology.2000
5Lang A,Schoonhoven R,Tuvia S,et al.Nuclear factor kap-paB in proliferation,activation,and apoptosis in rat hepatic stellate cells[].Journal of Hepatology.2000
6Okuno M,Sato T,Kitamoto T,et al.Increased9,13-di-cis-retinoic acid in rat hepatic fibrosis:implication for a poten-tial link between retinoid loss and TGF-beta mediated fibro-genesis in vivo[].Journal of Hepatology.1999
7Bonner JC.Regulation of PDGF and its receptors in fibrotic diseases[].Cytokine and Growth Factor Reviews.2004
8Kordes C,Brookmann S,Haussinger D,et al.Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1on activated pancre-atic stellate cells[].Pancreas.2005
9Saxena NK,Ikeda K,Rockey DC,et al.Leptin in hepatic fibrosis:evidence for increased collagen production in stel-late cells and lean littermates of ob/ob mice[].Hepatology.2002
10Ding X,Saxena NK,Lin S,et al.The roles of leptin and adiponectin:a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology[].American Journal of Pathology.2005
同被引文献23
1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1515
4Alter MJ,Kruszzon D,Nainan DV,et a1.The prevalence of hepatitis C virus infection in the united states,1988 through 1994[J].N Engl J Med,1999,341(8):556-562.
5Mehta K,Van Thiel DH,Shah N. Nonalcoholic fatty liver disease:pathogenesis and the role of antioxidants[J].{H}Nutrition Reviews,2002,(09):289-293.
6Angulo P. Use of ursodeoxycholic acid in patients with liver disease[J].{H}Current Gastroenterology Reports,2002.37-42.
7Tsukahara K,Kanai S,Ohta M. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats[J].{H}LIVER,1993.262-269.
8Heuman DM,Bajaj R. Ursodeoxycholate conjugates protect a-gainst disruption of cholesterol-rich membranes by bile salts[J].{H}GASTROENTEROLOGY,1994.1333-1341.
9Crosignani A,Budillon G,Cimino L. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis:a multicenter placebo-controlled study[J].{H}Hepato-Gastroenterology,1998.1624-1629.
